Evaluation of Breast Cancer Incidence Trends in the Karaganda Region of Kazakhstan
-
Nurbek Igissinov
,
Asem Toguzbayeva
,
Zhansaya Telmanova
,
Aida Baibusunova
,
Almazhan Abdykalikova
,
Gulnur Igissinova
,
Zarina Bilyalova
,
Olzhas Akyshev
,
Serikbay Orazbayev
,
Zhanar Kozhakhmetova
,
Zhanerke Azhetova
,
Gaukhar Nurtazinova
,
Yerlan Kuandykov
Abstract
Background: The study conducted a component analysis of the dynamics of the incidence of breast cancer (BC) in Karaganda region.
Methods: Primary data were for registered patients with BC (ICD 10–C50) in Kazakhstan, Karaganda region the period of 2009-2018. Evaluation of changes in BC incidence in the population of Karaganda was performed using component analysis according to the methodological recommendations.
Results: Overall, 4,391 new cases of BC and 1,202 deaths were recorded. The incidence rate increased from 44.4 (2009) to 72.7 in 2018 and the overall growth was 28.37 per 100,000 population of female, including due to the age structure – ∑ΔA=3.13, due to the risk of acquiring illness – ∑ΔR=22.69 and their combined effect – ∑ΔRA=2.56. The component analysis revealed that the increase in the number of patients with BC was mainly due to the growth of the population (ΔP=+3.7%), changes in its age structure (ΔA=+10.3%) and changes associated with the risk of acquiring illness (ΔR=+75.0%). The mortality rate in the region changed from 18.6 (2009) to 10.9 (2018) and tended to decrease.
Conclusion: The role of the influence of demographic factors and the risk of acquiring illness on the formation of the number of patients and the incidence of BC was evaluated. In this region, these indicators were the highest. The implementation of the results of this study is recommended in management of anticancer activities for BC.
1. Igissinov N, Toguzbayeva A, Turdaliyeva B, et al (2019). Breast Cancer in Megapolises of Kazakhstan: Epidemiological Assess-ment of Incidence and Mortality. Iran J Public Health, 48(7):1257-64.
2. Ferlay J, Ervik M, Lam F, et al. (2020A). Global Cancer Observatory: Cancer To-day. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today
3. DeSantis C, Howlader N, Cronin KA, Jemal A (2011). Breast cancer incidence rates in U.S. women are no longer declining. Can-cer Epidemiol Bio-markers Prev, 20:733–49.
4. DeSantis C, Ma J, Bryan L, Jemal A (2014). Breast cancer statistics, 2013. CA Cancer J Clin, 64(1):52–62.
5. Kolak A, Kamińska M, Sygit K, et al (2017) Primary and secondary prevention of breast cancer. Ann Agric Environ Med, 24(4):549-553.
6. Winters S, Martin C, Murphy D, Shokar NK (2017). Breast cancer epidemiology, pre-vention, and screening. Prog Mol Biol Transl Sci, 151:1-32.
7. Global Burden of Disease Cancer Collabo-ration (2017). Global, regional, and na-tional cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analy-sis for the global burden of disease study. JAMA Oncol, 3:524–48.
8. Sharma R (2019). Breast cancer incidence, mortality and mortality-to-incidence ratio (mir) are associated with human devel-opment, 1990–2016:evidence from global burden of disease study 2016. Breast Can-cer, 12:1–18.
9. Malvezzi M, Carioli G, Bertuccio P, et al (2019). European cancer mortality predic-tions for the year 2019 with focus on breast cancer. Ann Oncol, 30(5):781-87.
10. Chlebowski RT, Aragaki AK, Anderson GL, et al (2020). Dietary Modification and Breast Cancer Mortality: Long Term Fol-low-Up of the Women's Health Initiative Randomized Trial. J Clin Oncol, 38(13):1419-28.
11. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F (2019). Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and meth-ods. Int J Cancer, 144(8):1941–53.
12. Ferlay J, Laversanne M, Ervik M et al (2020B). Global Cancer Observatory: Cancer Tomorrow. Lyon, France: Interna-tional Agency for Research on Cancer. Available from: https://gco.iarc.fr/tomorrow, ac-cessed [12 May 2021]
13. Howell A, Anderson AS, Clarke RB, et al (2014). Risk determination and preven-tion of breast cancer. Breast Cancer Res, 16(5):446.
14. Coughlin SS, Smith SA (2015). The Impact of the Natural, Social, Built, and Policy Environments on BC. J Environ Health Sci, 1(3):1–7.
15. Sun YS, Zhao Z, Yang ZN, et al (2017). Risk factors and preventions of breast cancer. Int J Biol Sci, 13(11):1387-97.
16. Thorat MA, Balasubramanian R (2020). Breast cancer prevention in high-risk women. Best Pract Res Clin Obstet Gynaecol, 65:18-31.
17. Britt KL, Cuzick J, Phillips KA (2020). Key steps for effective breast cancer preven-tion. Nat Rev Cancer, 20(8):417-436.
18. Bilyalova Z, Igissinov N, Moore M, Igissi-nov S, Sarsenova S, Khassenova Z (2012). Epidemiological evaluation of breast cancer in ecological areas of Ka-zakhstan--association with pollution emissions. Asian Pac J Cancer Prev, 13(5):2341-44.
19. Beysebayev E, Bilyalova Z, Kozhakeeva L, Baissalbayeva A, Abiltayeva A (2015). Spatial and Temporal Epidemiological Assessment of Breast Cancer Incidence and Mortality in Kazakhstan, 1999-2013. Asian Pac J Cancer Prev, 16(15):6795-98.
20. Toguzbayeva AYA, Igissinov NS, Igissinova GS, Bilyalova ZA, Kulmirzayeva DM (2020). Spatial assessment of breast can-cer mortality in Kazakhstan. Medicine (Al-maty), 1-2(211-212):26-30.
21. The Bureau of National Statistics of the Agency for Strategic Planning and Re-forms of the Republic of Kazakhstan. Available from: https://stat.gov.kz/, ac-cessed [24 May 2021]
22. Ahmad OB, Boschi-Pinto C, Lopez AD, et al (2001). Age standardization of rates: a new who standard. GPE Discussion Paper Series: No.31 EIP/GPE/EBD World Health Organization, accessed [15 April 2021].
23. Merkov AM, Polyakov LE (1974). Sanitary statistics. Medicine, Leningrad, 384 p.
24. Glanc S (1999). Biomedical statistics. Practice, Moscow, 460 p.
25. Isabel dos Santos Silva (1999). Cancer epidemi-ology: principles and methods. IARC, Lyon, France, 442 p.
26. Dvoyrin VV, Aksel EM (1987). Component analysis of the dynamics of malignant neoplasms: guidelines. Moscow, 130 p.
27. WMA Declaration of Helsinki (2013) – Eth-ical Principles for Medical Research In-volving Human Subjects. Available from: https://www.wma.net/, accessed [19 March 2021].
28. Kamińska M, Ciszewski T, Łopacka-Szatan K, Miotła P, Starosławska E (2015). Breast cancer risk factors. Prz Menopauzal-ny, 14(3):196–202.
29. Bilyalova Z. Environmental epidemiology of breast cancer in Kazakhstan. [PhD the-sis]. Institute of Public Health, Astana Medical University, Kazakhstan; 2012.
2. Ferlay J, Ervik M, Lam F, et al. (2020A). Global Cancer Observatory: Cancer To-day. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today
3. DeSantis C, Howlader N, Cronin KA, Jemal A (2011). Breast cancer incidence rates in U.S. women are no longer declining. Can-cer Epidemiol Bio-markers Prev, 20:733–49.
4. DeSantis C, Ma J, Bryan L, Jemal A (2014). Breast cancer statistics, 2013. CA Cancer J Clin, 64(1):52–62.
5. Kolak A, Kamińska M, Sygit K, et al (2017) Primary and secondary prevention of breast cancer. Ann Agric Environ Med, 24(4):549-553.
6. Winters S, Martin C, Murphy D, Shokar NK (2017). Breast cancer epidemiology, pre-vention, and screening. Prog Mol Biol Transl Sci, 151:1-32.
7. Global Burden of Disease Cancer Collabo-ration (2017). Global, regional, and na-tional cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analy-sis for the global burden of disease study. JAMA Oncol, 3:524–48.
8. Sharma R (2019). Breast cancer incidence, mortality and mortality-to-incidence ratio (mir) are associated with human devel-opment, 1990–2016:evidence from global burden of disease study 2016. Breast Can-cer, 12:1–18.
9. Malvezzi M, Carioli G, Bertuccio P, et al (2019). European cancer mortality predic-tions for the year 2019 with focus on breast cancer. Ann Oncol, 30(5):781-87.
10. Chlebowski RT, Aragaki AK, Anderson GL, et al (2020). Dietary Modification and Breast Cancer Mortality: Long Term Fol-low-Up of the Women's Health Initiative Randomized Trial. J Clin Oncol, 38(13):1419-28.
11. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F (2019). Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and meth-ods. Int J Cancer, 144(8):1941–53.
12. Ferlay J, Laversanne M, Ervik M et al (2020B). Global Cancer Observatory: Cancer Tomorrow. Lyon, France: Interna-tional Agency for Research on Cancer. Available from: https://gco.iarc.fr/tomorrow, ac-cessed [12 May 2021]
13. Howell A, Anderson AS, Clarke RB, et al (2014). Risk determination and preven-tion of breast cancer. Breast Cancer Res, 16(5):446.
14. Coughlin SS, Smith SA (2015). The Impact of the Natural, Social, Built, and Policy Environments on BC. J Environ Health Sci, 1(3):1–7.
15. Sun YS, Zhao Z, Yang ZN, et al (2017). Risk factors and preventions of breast cancer. Int J Biol Sci, 13(11):1387-97.
16. Thorat MA, Balasubramanian R (2020). Breast cancer prevention in high-risk women. Best Pract Res Clin Obstet Gynaecol, 65:18-31.
17. Britt KL, Cuzick J, Phillips KA (2020). Key steps for effective breast cancer preven-tion. Nat Rev Cancer, 20(8):417-436.
18. Bilyalova Z, Igissinov N, Moore M, Igissi-nov S, Sarsenova S, Khassenova Z (2012). Epidemiological evaluation of breast cancer in ecological areas of Ka-zakhstan--association with pollution emissions. Asian Pac J Cancer Prev, 13(5):2341-44.
19. Beysebayev E, Bilyalova Z, Kozhakeeva L, Baissalbayeva A, Abiltayeva A (2015). Spatial and Temporal Epidemiological Assessment of Breast Cancer Incidence and Mortality in Kazakhstan, 1999-2013. Asian Pac J Cancer Prev, 16(15):6795-98.
20. Toguzbayeva AYA, Igissinov NS, Igissinova GS, Bilyalova ZA, Kulmirzayeva DM (2020). Spatial assessment of breast can-cer mortality in Kazakhstan. Medicine (Al-maty), 1-2(211-212):26-30.
21. The Bureau of National Statistics of the Agency for Strategic Planning and Re-forms of the Republic of Kazakhstan. Available from: https://stat.gov.kz/, ac-cessed [24 May 2021]
22. Ahmad OB, Boschi-Pinto C, Lopez AD, et al (2001). Age standardization of rates: a new who standard. GPE Discussion Paper Series: No.31 EIP/GPE/EBD World Health Organization, accessed [15 April 2021].
23. Merkov AM, Polyakov LE (1974). Sanitary statistics. Medicine, Leningrad, 384 p.
24. Glanc S (1999). Biomedical statistics. Practice, Moscow, 460 p.
25. Isabel dos Santos Silva (1999). Cancer epidemi-ology: principles and methods. IARC, Lyon, France, 442 p.
26. Dvoyrin VV, Aksel EM (1987). Component analysis of the dynamics of malignant neoplasms: guidelines. Moscow, 130 p.
27. WMA Declaration of Helsinki (2013) – Eth-ical Principles for Medical Research In-volving Human Subjects. Available from: https://www.wma.net/, accessed [19 March 2021].
28. Kamińska M, Ciszewski T, Łopacka-Szatan K, Miotła P, Starosławska E (2015). Breast cancer risk factors. Prz Menopauzal-ny, 14(3):196–202.
29. Bilyalova Z. Environmental epidemiology of breast cancer in Kazakhstan. [PhD the-sis]. Institute of Public Health, Astana Medical University, Kazakhstan; 2012.
| Files | ||
| Issue | Vol 51 No 10 (2022) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijph.v51i10.10989 | |
| Keywords | ||
| Breast cancer Incidence Trends Component analysis | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Igissinov N, Toguzbayeva A, Telmanova Z, Baibusunova A, Abdykalikova A, Igissinova G, Bilyalova Z, Akyshev O, Orazbayev S, Kozhakhmetova Z, Azhetova Z, Nurtazinova G, Kuandykov Y. Evaluation of Breast Cancer Incidence Trends in the Karaganda Region of Kazakhstan. Iran J Public Health. 2022;51(10):2308-2316.
